Clinical evaluation of new vitrectomy system:EVA

Clinical evaluation of new vitrectomy system:EVA - Clinical evaluation of EVA

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011833

Enrollment

Registered

2014-02-01

Start date

2014-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retinal detachment, Epimacular proliferation, macular hole, Diabetic retinopathy, Retinal vein occlusion, Vitreous hemorrhage

Interventions

Perform primary vitrectomy using a new vitrectomy system EVA, excluidng reoperation.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who are in need of vitrectomy for retinal detachment, epimacular proliferation, macular hole, diabetic retinopathy, or vitreous hemorrhage.

Exclusion criteria

Exclusion criteria: Patients who does not consent to this study

Design outcomes

Primary

Measure	Time frame
Surgical time for each procedure, complications, and volume of intraocular irrigation at the time of surgery	—

Secondary

Measure	Time frame
Usability of vitrectomy system	—

Countries

Japan

Contacts

Public ContactShunji Kusaka

Sakai Hospital Kinki University Faculty of Medicine Department of Ophthalmology

kusaka-ns@umin.net072-299-1120

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026